PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$387.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
21 July 2023
Digital Technologies in Movement Disorders, Volume Five updates on the latest advances in new technologies for the care of common conditions, including Parkinson’s disease and other diseases. The book has been organized in four differentiated sections with chapters that cover an Introduction, key concepts, and overview of digital solutions, Applications of AI in MD, Digital Biomarkers in MD, Sensors basic concepts for the MD specialist, Wearable systems in MD, Quantitative gait analysis, The challenges and opportunities of remote evaluation in MD, Telemedicine in MD, ePROs, eCOA and other digital health solutions, HIFU, Telerrehabilition and other therapeutical applications of technology, and more.

Volume editor:   , , , , ,
Imprint:   Academic Press Inc
Country of Publication:   United Kingdom
Dimensions:   Height: 229mm,  Width: 152mm, 
Weight:   450g
ISBN:   9780323992374
ISBN 10:   0323992374
Series:   International Review of Movement Disorders
Pages:   312
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

"Dr. Sánchez Ferro specialized in neurology at the Hospital 12 de Octubre in Madrid (Spain). In the same center, he was trained specifically for the management of Parkinson's disease thanks to a program of the Carlos III Research Institute (Río Hortega Program). During this period, he visited prestigious centers such as the ""Hertie Institut"" in Tübingen (Germany) and the ""MINDS laboratory"" from Harvard University where he also received training in neurodegenerative diseases. In 2013, Dr. Sánchez Ferro received a scholarship from a program of the Community of Madrid and the Massachusetts Institute of Technology (Cambridge, USA) to be part of a biomedical innovation program. As part of it, he developed new methods for the objective quantification of Parkinson's disease signs. Currently, Dr. Sánchez-Ferro continues applying these skills in his position as neurologist and researcher at 12 de Octubre Hospital and Chief Medical Officer of Leuko Labs. He is also Director of the Clinical Outcomes Assessment Program at the International Parkinson and Movement Disorders Society (MDS) and is an active member of the Technology Study Group of the MDS Society. Dr Monje specialized in neurology at the Hospital Clínico San Carlos in Madrid (Spain). She received her PhD in Neuroscience from Universidad Autónoma de Madrid working in a progressive model of Parkinson’s disease in non-human primate. She posteriorly pursued a clinical and research fellowship in Movement in HM-CINAC, where she got experience in new technologies for the objective quantification of movement disorders. Currently, Dr. Monje works as postdoctoral scholar in Northwestern University, Chicago (USA). She is the co-Chair of the Electronic Clinical Outcomes Assessment Program at the International Parkinson and Movement Disorders Society (MDS)."

See Also